[HTML][HTML] Squamous cell carcinoma in patients with inherited epidermolysis bullosa: Review of current literature

D Bonamonte, A Filoni, A De Marco, L Lospalluti… - Cells, 2022 - mdpi.com
Epidermolysis bullosa (EB) is a group of rare congenital diseases caused by mutations in
structural proteins of the dermal/epidermal junction that are characterized by extreme …

[HTML][HTML] Type VII collagen deficiency in the oncogenesis of cutaneous squamous cell carcinoma in dystrophic epidermolysis bullosa

AP South, M Laimer, M Gueye, JY Sui… - Journal of Investigative …, 2023 - Elsevier
Dystrophic epidermolysis bullosa is a rare genetic skin disorder caused by COL7A1
sequence variations that result in type VII collagen deficits and cutaneous and …

[HTML][HTML] European consensus-based interdisciplinary guideline for invasive cutaneous squamous cell carcinoma. Part 1: Diagnostics and prevention–Update 2023

AJ Stratigos, C Garbe, C Dessinioti, C Lebbe… - European Journal of …, 2023 - Elsevier
Invasive cutaneous squamous cell carcinoma (cSCC) is one of the most common cancers in
white populations, accounting for 20% of all cutaneous malignancies. Overall, cSCC mostly …

[HTML][HTML] Inflammation-mediated fibroblast activation and immune dysregulation in collagen VII-deficient skin

M Anderson-Crannage, AM Ascensión… - Frontiers in …, 2023 - frontiersin.org
Inflammation is known to play a critical role in all stages of tumorigenesis; however, less is
known about how it predisposes the tissue microenvironment preceding tumor formation …

Epidermolysis-bullosa-associated squamous cell carcinomas support an immunosuppressive tumor microenvironment: prospects for immunotherapy

D Rafei-Shamsabadi, L Scholten, S Lu, D Castiglia… - Cancers, 2024 - mdpi.com
Simple Summary Cutaneous squamous cell carcinomas (SCCs) are the most common
tumors in patients suffering from the genetic disorder epidermolysis bullosa (EB). These …

MicroRNA-200b-mediated reversion of a spectrum of epithelial-to-mesenchymal transition states in recessive dystrophic epidermolysis bullosa squamous cell …

J Illmer, R Zauner, J Piñón Hofbauer… - British Journal of …, 2024 - academic.oup.com
Background Cutaneous squamous cell carcinoma (SCC) is the leading cause of death in
patients with recessive dystrophic epidermolysis bullosa (RDEB). However, the survival time …

[HTML][HTML] Cytosine deaminase base editing to restore COL7A1 in dystrophic epidermolysis bullosa human: murine skin model

G Naso, SA Gkazi, C Georgiadis, V Jayarajan… - JID Innovations, 2023 - Elsevier
Recessive dystrophic epidermolysis bullosa is a debilitating blistering skin disorder caused
by loss-of-function mutations in COL7A1, which encodes type VII collagen, the main …

[HTML][HTML] Itch in recessive dystrophic epidermolysis bullosa: findings of PEBLES, a prospective register study

JE Mellerio, EI Pillay, L Ledwaba-Chapman… - Orphanet Journal of …, 2023 - Springer
Background Itch is common and distressing in epidermolysis bullosa (EB) but has not
previously been studied in depth in different recessive dystrophic EB (RDEB) subtypes …

[HTML][HTML] Variable outcome of immunotherapy in advanced multiple cutaneous squamous cell carcinomas in two patients with recessive dystrophic epidermolysis …

L Trefzer, L SCHOLTEN… - Acta Dermato …, 2023 - ncbi.nlm.nih.gov
Cutaneous squamous cell carcinoma (cSCC) is a major complication of recessive dystrophic
epidermolysis bullosa (RDEB) that has high morbidity and mortality rates and unmet …

Antiviral drugs prolong survival in murine recessive dystrophic epidermolysis bullosa

G Tartaglia, I Fuentes, N Patel, A Varughese… - EMBO Molecular …, 2024 - embopress.org
Recessive dystrophic epidermolysis bullosa (RDEB) is a rare inherited skin disease
characterized by defects in type VII collagen leading to a range of fibrotic pathologies …